Americans can now vaccinate themselves against the flu without the assistance of a healthcare worker.
The Federal Trade Commission said that it is suing the three major US pharmacy benefit managers over their role in the ...
Apellis has had its European ambitions dashed once again after regulators reaffirmed their decision to not recommend the ...
Sanofi released new Phase 3 data for its BTK inhibitor tolebrutinib in non-relapsing secondary progressive multiple sclerosis ...
Yuhan and Johnson & Johnson Innovative Medicine (JJIM), formerly known as Janssen, ended a research project after securing ...
After a second review, the FDA approved Zevra Therapeutics’ treatment for Niemann-Pick disease type C, a progressive rare ...
Gilead Science’s Kite Pharma is separating from its cell therapy joint venture with Fosun Pharma in China, handing Fosun the ...
Novo Nordisk has ended one of the multiple trials testing the lead oral drug from its $1.1 billion Forma Therapeutics buyout, ...
Aligos Therapeutics' oral treatment for an advanced form of fatty liver disease reported positive results in a Phase 2 trial, ...
Novo Nordisk's $1 billion bet last year on a small Canadian biotech could expand the Danish drug giant's arsenal of obesity medicines, but it will first have to address safety concerns. On Friday, Nov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback